# Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines

> **NCT01782066** · PHASE1,PHASE2 · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Meningococcal Disease

## Interventions

- **BIOLOGICAL:** MEN-ACYW135 reduced-dose intradermal administration

## Key facts

- **NCT ID:** NCT01782066
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782066, "Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01782066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*